{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo%2FEnoxaparin&page=2", "query": { "intervention": "Placebo/Enoxaparin", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 28, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo%2FEnoxaparin&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo%2FEnoxaparin&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-01T22:13:11.960Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01014403", "title": "Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Venous Thromboembolism", "Traumatic Brain Injury" ], "interventions": [ { "name": "enoxaparin", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 62, "start_date": "2009-11", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2021-01-13", "last_synced_at": "2026-10-01T22:13:11.960Z", "location_count": 2, "location_summary": "Dallas, Texas • Tyler, Texas", "locations": [ { "city": "Dallas", "state": "Texas" }, { "city": "Tyler", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01014403" }, { "nct_id": "NCT02271113", "title": "Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "GMI-1271", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Enoxaparin Sodium (Lovenox®)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlycoMimetics Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 32, "start_date": "2014-10", "completion_date": "2016-03", "has_results": false, "last_update_posted_date": "2018-02-27", "last_synced_at": "2026-10-01T22:13:11.960Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02271113" }, { "nct_id": "NCT03891524", "title": "A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Arthroplasty, Replacement, Knee" ], "interventions": [ { "name": "JNJ-70033093 25 mg", "type": "DRUG" }, { "name": "JNJ-70033093 50 mg", "type": "DRUG" }, { "name": "JNJ-70033093 100 mg", "type": "DRUG" }, { "name": "JNJ-70033093 200 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Enoxaparin 40 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 1242, "start_date": "2019-06-17", "completion_date": "2021-04-06", "has_results": true, "last_update_posted_date": "2025-03-30", "last_synced_at": "2026-10-01T22:13:11.960Z", "location_count": 9, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 6 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Torrance", "state": "California" }, { "city": "Englewood", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03891524" }, { "nct_id": "NCT00457002", "title": "Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Venous Thrombosis", "Pulmonary Embolism" ], "interventions": [ { "name": "Apixaban", "type": "DRUG" }, { "name": "Enoxaparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 6758, "start_date": "2007-06", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2015-12-08", "last_synced_at": "2026-10-01T22:13:11.960Z", "location_count": 48, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 42 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Fort Smith", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00457002" }, { "nct_id": "NCT03083704", "title": "A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Bleeding" ], "interventions": [ { "name": "Andexanet alfa (Gen 1 Process 2)", "type": "BIOLOGICAL" }, { "name": "Apixaban 5 MG", "type": "DRUG" }, { "name": "Rivaroxaban 20 MG", "type": "DRUG" }, { "name": "Enoxaparin sodium", "type": "DRUG" }, { "name": "Edoxaban 60 MG", "type": "DRUG" }, { "name": "Andexanet alfa (Gen 2)", "type": "BIOLOGICAL" }, { "name": "Andexanet alfa (Gen 1 Process 3)", "type": "BIOLOGICAL" }, { "name": "Apixaban 10 MG", "type": "DRUG" }, { "name": "Rivaroxaban 10 MG", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Portola Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 153, "start_date": "2017-02-26", "completion_date": "2017-09-28", "has_results": false, "last_update_posted_date": "2023-08-08", "last_synced_at": "2026-10-01T22:13:11.960Z", "location_count": 1, "location_summary": "Cypress, California", "locations": [ { "city": "Cypress", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03083704" }, { "nct_id": "NCT07015905", "title": "REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Venous Thromboembolism (VTE)" ], "interventions": [ { "name": "REGN7508", "type": "DRUG" }, { "name": "Apixaban", "type": "DRUG" }, { "name": "Enoxaparin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2000, "start_date": "2025-06-25", "completion_date": "2027-05-12", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-01T22:13:11.960Z", "location_count": 20, "location_summary": "Sheffield, Alabama • Riverside, California • Englewood, Colorado + 16 more", "locations": [ { "city": "Sheffield", "state": "Alabama" }, { "city": "Riverside", "state": "California" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Delray Beach", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07015905" }, { "nct_id": "NCT02206100", "title": "PK and PD of Single, Escalating Doses of PER977 Following Enoxaparin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "PER977", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "enoxaparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 40, "start_date": "2014-04", "completion_date": "2014-08", "has_results": false, "last_update_posted_date": "2020-05-21", "last_synced_at": "2026-10-01T22:13:11.960Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02206100" }, { "nct_id": "NCT00643201", "title": "Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Venous Thrombosis" ], "interventions": [ { "name": "Enoxaparin", "type": "DRUG" }, { "name": "warfarin", "type": "DRUG" }, { "name": "Placebo for apixaban", "type": "DRUG" }, { "name": "Placebo for enoxaparin", "type": "DRUG" }, { "name": "Placebo for warfarin", "type": "DRUG" }, { "name": "apixaban", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5614, "start_date": "2008-07", "completion_date": "2013-03", "has_results": true, "last_update_posted_date": "2014-04-21", "last_synced_at": "2026-10-01T22:13:11.960Z", "location_count": 73, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Fort Smith, Arkansas + 68 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Banning", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00643201" }, { "nct_id": "NCT04558125", "title": "Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Embolism", "COVID" ], "interventions": [ { "name": "TNKase", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Enoxaparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 2, "start_date": "2020-09-08", "completion_date": "2021-08-08", "has_results": true, "last_update_posted_date": "2021-10-26", "last_synced_at": "2026-10-01T22:13:11.960Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04558125" }, { "nct_id": "NCT00097357", "title": "BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Venous Thrombosis", "Pulmonary Embolism" ], "interventions": [ { "name": "Apixaban", "type": "DRUG" }, { "name": "Enoxaparin", "type": "DRUG" }, { "name": "Warfarin", "type": "DRUG" }, { "name": "Enoxaparin Placebo", "type": "DRUG" }, { "name": "Apixaban Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 1238, "start_date": "2004-10", "completion_date": "2005-12", "has_results": false, "last_update_posted_date": "2010-03-02", "last_synced_at": "2026-10-01T22:13:11.960Z", "location_count": 72, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Northport, Alabama + 69 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Northport", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00097357" } ] }